ImmunityBio Inc header image

ImmunityBio Inc

IBRX

Equity

ISIN null / Valor 110468647

NASDAQ (2026-10-27)
USD 8.63+10.5%

ImmunityBio Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

ImmunityBio, Inc. is a U.S.-based clinical-stage biopharmaceutical company that develops immunotherapies for cancer and infectious diseases, operating as a publicly traded entity (NASDAQ: IBRX). The firm’s research portfolio centers on immune-stimulating biologics and cell‑based approaches, most notably an IL‑15 receptor agonist known as N-803 (Anktiva), alongside programs in adoptive cell therapy and therapeutic vaccines, and it advances those candidates largely through early- and mid-stage clinical trials. ImmunityBio’s development strategy emphasizes using its immune-activating platforms in combination with existing cancer treatments, such as checkpoint inhibitors, to enhance anti-tumor responses, while pursuing clinical indications across multiple tumor types and infectious-disease applications.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

224%1Y
248%3Y
10.8%5Y

Performance

101%1Y
105%3Y
113%5Y

Volatility

Market cap

9146 M

Market cap (USD)

Daily traded volume (Shares)

10,508,798

Daily traded volume (Shares)

1 day high/low

2.755 / 2.575

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

LeMaitre Vascular inc
LeMaitre Vascular inc LeMaitre Vascular inc Valor: 2755054
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.62%USD 83.79
Janux Therapeutics Inc
Janux Therapeutics Inc Janux Therapeutics Inc Valor: 111742522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.42%USD 17.26
DBV Technologies SA
DBV Technologies SA DBV Technologies SA Valor: 2857349
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.24%EUR 1.85
BACHEM HOLDING LTD
BACHEM HOLDING LTD BACHEM HOLDING LTD Valor: 117649372
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.60%CHF 83.35
MedCap AB
MedCap AB MedCap AB Valor: 34063678
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.72%SEK 543.00
Vimian Group AB
Vimian Group AB Vimian Group AB Valor: 111662981
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.25%SEK 40.00
Dynavox Group AB
Dynavox Group AB Dynavox Group AB Valor: 114900704
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.90%SEK 72.50
Align Technology Inc
Align Technology Inc Align Technology Inc Valor: 1159441
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.20%USD 151.95
Tempus AI Inc
Tempus AI Inc Tempus AI Inc Valor: 135855934
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
7.43%USD 72.15
Lineage Inc
Lineage Inc Lineage Inc Valor: 136372357
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.03%USD 35.38